Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
Authors
Keywords
-
Journal
Clinical & Developmental Immunology
Volume 2010, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2011-01-25
DOI
10.1155/2010/791603
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Tumor Growth by NK1.1+ Cells and CD8+ T Cells Activated by IL-15 through Receptor /Common Signaling in trans
- (2014) J. Rowley et al. JOURNAL OF IMMUNOLOGY
- Serum sFas, Leptin, and VEGF in Patients with Ovarian Cancer and Benign Tumors
- (2010) M. M. Vysotskii et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Immune responses to malignancies
- (2010) Theresa L. Whiteside JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CD4+ T Cells Elicit Host Immune Responses to MHC Class II- Ovarian Cancer through CCL5 Secretion and CD40-Mediated Licensing of Dendritic Cells
- (2010) Y. C. Nesbeth et al. JOURNAL OF IMMUNOLOGY
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
- (2009) X B Trinh et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
- (2009) Hiroyuki Suzuki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer
- (2009) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- BRCA1 and implications for response to chemotherapy in ovarian cancer
- (2009) Jennifer E. Quinn et al. GYNECOLOGIC ONCOLOGY
- Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model
- (2009) Jun Dou et al. IMMUNOBIOLOGY
- Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
- (2009) Dorothée Duluc et al. INTERNATIONAL JOURNAL OF CANCER
- The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells
- (2009) Luigi Maddaluno et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment
- (2009) A. Barber et al. JOURNAL OF IMMUNOLOGY
- Interleukin 2-mediated Conversion of Ovarian Cancer-associated CD4+ Regulatory T Cells Into Proinflammatory Interleukin 17-producing Helper T Cells
- (2009) Lucie Leveque et al. JOURNAL OF IMMUNOTHERAPY
- Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN
- (2009) Michelandrea De Cesare et al. JOURNAL OF IMMUNOTHERAPY
- Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma
- (2009) Li-li Chen et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Interleukin-18 gene promoter and serum level in women with ovarian cancer
- (2009) Alamtaj Samsami Dehaghani et al. MOLECULAR BIOLOGY REPORTS
- The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium
- (2008) S. Zecchini et al. CANCER RESEARCH
- Ascites Specific Inhibition of CD1d-Mediated Activation of Natural Killer T Cells
- (2008) T. J. Webb et al. CLINICAL CANCER RESEARCH
- Immunotherapy opportunities in ovarian cancer
- (2008) Christina S Chu et al. Expert Review of Anticancer Therapy
- Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
- (2008) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
- (2008) Jason Konner et al. GYNECOLOGIC ONCOLOGY
- Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
- (2008) Robert E. Bristow et al. GYNECOLOGIC ONCOLOGY
- Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
- (2008) R Chen et al. ONCOGENE
- Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin
- (2008) Andreas Gaumann et al. TRANSPLANT INTERNATIONAL
- Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
- (2007) Aristotelis Bamias et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now